Tiger Global Management’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-12,494
Closed -$8.82M 99
2020
Q3
$8.82M Hold
12,494
0.02% 67
2020
Q2
$8.74M Hold
12,494
0.03% 54
2020
Q1
$4.37M Sell
12,494
-33,016
-73% -$23.4M 0.03% 57
2019
Q4
$28.6M Buy
+45,510
New +$22.3M 0.16% 44

Other funds holding CDLX

Tiger Global Management's CDLX Position: Q4 2020 in Review

Tiger Global Management sold out of Cardlytics (CDLX) in Q4 2020, closing a stake of 12,494 shares — an estimated $8.82M sold.

Tiger Global Management first reported a position in CDLX in Q4 2019 and held it in 4 quarters. The position peaked at $28.6M in Q4 2019. 195 funds tracked by Wall St. Rank hold CDLX as of Q4 2020.

  • Tiger Global Management reported no remaining Cardlytics position as of Q4 2020 after selling out during the quarter.
  • Tiger Global Management sold 12,494 Cardlytics shares in Q4 2020, an estimated $8.82M.
  • Tiger Global Management first reported a position in Cardlytics in Q4 2019 and held it in 4 quarters.
  • Tiger Global Management's Cardlytics position peaked at $28.6M in Q4 2019.
  • 195 funds tracked by Wall St. Rank held Cardlytics as of Q4 2020.

Based on Tiger Global Management's 13F filing for Q4 2020, filed 16 Feb 2021.